Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedJun 01, 2025
DataAggregated Company Financials
Companies5
  • 7D0.2%
  • 3M-10.2%
  • 1Y-33.3%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 1.5%, driven by a pullback from Norbel Baby of 3.6%. However, the industry is down 34% over the past year. As for the next few years, earnings are expected to grow by 12% per annum.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 01 Jun 2025NT$32.4bNT$32.8bNT$754.7m30.2x43x1x
Tue, 29 Apr 2025NT$32.8bNT$32.3bNT$718.2m37.6x45.6x1x
Thu, 27 Mar 2025NT$36.4bNT$32.1bNT$748.3m39.6x48.6x1.1x
Sat, 22 Feb 2025NT$36.3bNT$31.8bNT$755.8m42.2x48x1.1x
Mon, 20 Jan 2025NT$32.5bNT$31.8bNT$755.8m43x43x1x
Wed, 18 Dec 2024NT$33.5bNT$31.8bNT$755.8m45.4x44.4x1.1x
Fri, 15 Nov 2024NT$38.1bNT$31.7bNT$777.8m109.8x48.9x1.2x
Sun, 13 Oct 2024NT$40.6bNT$31.0bNT$840.8m113.3x48.3x1.3x
Tue, 10 Sep 2024NT$38.1bNT$31.0bNT$840.8m111x45.3x1.2x
Thu, 08 Aug 2024NT$41.0bNT$30.7bNT$873.1m76x47x1.3x
Sat, 06 Jul 2024NT$44.4bNT$30.7bNT$873.1m78.8x50.8x1.4x
Mon, 03 Jun 2024NT$48.5bNT$30.7bNT$873.1m82.5x55.5x1.6x
Wed, 01 May 2024NT$49.0bNT$30.3bNT$935.7m58.5x52.3x1.6x
Fri, 29 Mar 2024NT$51.5bNT$30.2bNT$941.1m57x54.7x1.7x
Sun, 25 Feb 2024NT$53.1bNT$29.9bNT$964.0m59.9x55.1x1.8x
Tue, 23 Jan 2024NT$52.9bNT$30.0bNT$1.0b49.2x50.7x1.8x
Thu, 21 Dec 2023NT$53.0bNT$26.8bNT$949.0m58.1x55.8x2x
Sat, 18 Nov 2023NT$52.1bNT$26.8bNT$949.0m57.7x54.9x1.9x
Mon, 16 Oct 2023NT$55.4bNT$26.3bNT$1.0b46.2x54.3x2.1x
Wed, 13 Sep 2023NT$53.1bNT$26.3bNT$1.0b45.8x52x2x
Fri, 11 Aug 2023NT$54.7bNT$26.7bNT$1.3b24x43.3x2x
Sun, 09 Jul 2023NT$53.2bNT$26.8bNT$1.3b28.5x42.2x2x
Tue, 06 Jun 2023NT$51.3bNT$26.6bNT$1.3b23.4x40.3x1.9x
Thu, 04 May 2023NT$56.6bNT$26.0bNT$1.2b24.2x45.8x2.2x
Sat, 01 Apr 2023NT$46.2bNT$25.8bNT$1.2b19x37.8x1.8x
Mon, 27 Feb 2023NT$42.5bNT$25.1bNT$1.2b17.6x36.5x1.7x
Wed, 25 Jan 2023NT$38.1bNT$25.1bNT$1.2b15.4x32.7x1.5x
Fri, 23 Dec 2022NT$36.5bNT$25.1bNT$1.2b15.4x31.3x1.5x
Sun, 20 Nov 2022NT$33.8bNT$25.1bNT$1.2b14.6x29x1.3x
Tue, 18 Oct 2022NT$32.5bNT$24.3bNT$1.1b19.6x30.9x1.3x
Thu, 15 Sep 2022NT$33.8bNT$24.3bNT$1.1b21.1x32.2x1.4x
Sat, 13 Aug 2022NT$32.3bNT$22.5bNT$789.4m36.2x40.9x1.4x
Mon, 11 Jul 2022NT$28.0bNT$22.5bNT$789.4m34.3x35.5x1.2x
Wed, 08 Jun 2022NT$35.0bNT$22.5bNT$789.4m36.4x44.3x1.6x
Price to Earnings Ratio

44.3x


Total Market Cap: NT$35.0bTotal Earnings: NT$789.4mTotal Revenue: NT$22.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 44.9x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 44.9x.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.98x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market-1.31%
Consumer Staples-0.99%
Food and Staples Retail-1.57%
Drug Retail0.25%
Big Box Super Stores0%0
Food Distributors-0.44%
Food Retail-1.79%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6469 Great Tree PharmacyNT$159.001.3%
+NT$264.5m		-31.6%PE31.3x
6929 We Can MedicinesNT$34.351.2%
+NT$18.0m		-52.3%PS0.5x
4175 MedFirst Healthcare ServicesNT$67.700.6%
+NT$16.9m		-9.1%PE24.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4175

NT$67.70

MedFirst Healthcare Services

7D

0.6%

1Y

-9.1%

6844

NT$108.50

Norbel Baby

7D

-2.7%

1Y

-37.5%

6929

NT$34.35

We Can Medicines

7D

1.2%

1Y

-52.3%

6469

NT$159.00

Great Tree Pharmacy

7D

1.3%

1Y

-31.6%

7731

NT$5.81

MARX Biotech

7D

-3.5%

1Y

-41.2%